» Articles » PMID: 17671767

Complete Remission of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and Lymph Node Metastases by Arterial Infusion of 5-fluorouracil and Interferon-alpha Combination Therapy Following Hepatic Resection

Overview
Journal J Gastroenterol
Specialty Gastroenterology
Date 2007 Aug 3
PMID 17671767
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

We report two cases of hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) and lymph node (LN) metastases successfully treated by hepatic arterial infusion of 5-fluorouracil (5-FU) combined with systemic injection of interferon (IFN)-alpha following hepatic resection for the liver tumor. Complete remission was obtained. Case 1 was a 51-year-old man who had HCC in the right lobe of the liver with PVTT and multiple intrahepatic metastases. He also had abdominal and mediastinal LN metastases. Case 2 was a 53-year-old man who had diffuse-type HCC in the right lobe of the liver with PVTT and intrahepatic metastases. A chest computed tomography scan revealed lymph nodes enlarged to 1.0 cm from the mediastinum to the left supraclavicular space. Both patients underwent the hepatectomy to reduce the tumor volumes and remove the PVTT to relieve portal vein obstruction. Following the surgery, the patients underwent IFN-alpha/5-FU combination therapy. Three months after this combined therapy, tumor markers (both alpha-fetoprotein and protein induced by vitamin K absence or antagonist II) returned to the normal range and residual tumors in the liver disappeared. The patients are alive without any recurrence more than 1 year after initial treatment. IFN-alpha/5-FU combined therapy following hepatic resection is a promising modality for the treatment of advanced HCC with LN metastasis.

Citing Articles

Surgical treatment after hepatic arterial infusion chemotherapy for hepatocellular carcinoma extending into the right atrium.

Kurahashi S, Sano T, Natsume S, Senda Y, Yamaura H, Inaba Y Surg Case Rep. 2015; 1(1):47.

PMID: 26366344 PMC: 4560137. DOI: 10.1186/s40792-015-0047-z.


Autologous formalin-fixed tumor vaccine suppressed re-recurrence of HCV-related hepatocellular carcinoma following 29 unsuccessful treatments with extensive conventional therapy: a case report.

Inui T, Ohno T World J Surg Oncol. 2012; 10:144.

PMID: 22789008 PMC: 3443042. DOI: 10.1186/1477-7819-10-144.


Hepatocellular carcinoma, with portal thrombus after viral eradication, disappeared by 5-fluorouracil and interferon.

Miura T, Suzuki N, Nakamura J, Yamada S, Miura T, Yanagi M World J Hepatol. 2010; 2(11):416-8.

PMID: 21173911 PMC: 3004036. DOI: 10.4254/wjh.v2.i11.416.


TLR3 induction by anticancer drugs potentiates poly I:C-induced tumor cell apoptosis.

Taura M, Fukuda R, Suico M, Eguma A, Koga T, Shuto T Cancer Sci. 2010; 101(7):1610-7.

PMID: 20367642 PMC: 11159143. DOI: 10.1111/j.1349-7006.2010.01567.x.

References
1.
Okusaka T, Okada S, Ishii H, Nose H, Nagahama H, Nakasuka H . Prognosis of hepatocellular carcinoma patients with extrahepatic metastases. Hepatogastroenterology. 1997; 44(13):251-7. View

2.
Obi S, Yoshida H, Toune R, Unuma T, Kanda M, Sato S . Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion. Cancer. 2006; 106(9):1990-7. DOI: 10.1002/cncr.21832. View

3.
Yatsuhashi H, Fujino T, Matsumoto T, Inoue O, Koga M, Yano M . Immunohistochemical analysis of hepatic interferon alpha-beta receptor level: relationship between receptor expression and response to interferon therapy in patients with chronic hepatitis C. J Hepatol. 1999; 30(6):995-1003. DOI: 10.1016/s0168-8278(99)80252-9. View

4.
Kondo M, Nagano H, Sakon M, Yamamoto H, Morimoto O, Arai I . Expression of interferon alpha/beta receptor in human hepatocellular carcinoma. Int J Oncol. 2000; 17(1):83-8. View

5.
Okada S, Okazaki N, Nose H, YOSHIMORI M, Aoki K . Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Hepatology. 1992; 16(1):112-7. DOI: 10.1002/hep.1840160119. View